LCAT and Hyperglycemia: In contrast, hyperglycemia-induced glycation of apolipoprotein A1 inhibits its ability to activate lecithin-cholesterol acyltransferase, resulting in a 40% reduction in HDL cholesterol efflux efficiency in diabetic models [26].